AACR approaches, along with ASCO abstract titles.
ApexOnco Front Page
Recent articles
A biliary tract cancer trial hits on response rate, but survival data will be key.
Following its odronextamab knockback, Regeneron now faces a delay to linvoseltamab.
First-in-human trial initiations feature Interius, Umoja and Vironexis.
BioNTech and Genmab's acasunlimab is the latest 4-1BB project to stumble.
NVL-330 features among the latest crop of industry projects newly into human trials.
Western data on EO-3021 fail to live up to the billing of a Chinese trial.
Darzalex added another string to its bow, while Kisqali’s early use has been delayed.